Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Multidrug-resistant strains are frequent causes of nosocomial infections. The majority of nosocomial infections, particularly in critical care units (ICU), have been linked to , which has major clinical significance. The current paper attempts to identify the potential risk and prognosis factors for acquiring an infection due to compared to that of other nosocomial bacteria. In our study, we employed antibiotics generally prescribed for the initial course of treatment such as colistin, meropenem, amikacin, trimethoprime-sulfamethoxazole, levofloxacin, gentamicin, ciprofloxacin, and piperacillin-tazobactam. We found that the isolated were resistant at a high rate to meropenem, piperacillin-tazobactam, amikacin, levofloxacin, and ciprofloxacin, while they were partially susceptible to trimethoprim-sulfamethoxazole. Our study revealed that was most susceptible to gentamicin and colistin at 85.8% and 92.9%, respectively, whereas the combination of colistin and trimethoprim/sulfamethoxazole was 100% active. The patients were the primary source of infection with , followed by inanimate objects present in the ICU and hospital premises, and then the hospital staff who were taking care of the ICU patients. Gentamicin and colistin were the most sensitive antibiotics; of the 13 tested in total, the rate of drug resistance was above 50%. The very high rate of antibiotic resistance is alarming.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963463PMC
http://dx.doi.org/10.3390/tropicalmed8020108DOI Listing

Publication Analysis

Top Keywords

multidrug-resistant strains
8
nosocomial infections
8
high rate
8
gentamicin colistin
8
occurrence multidrug-resistant
4
strains spp
4
spp emerging
4
emerging threat
4
threat nosocomial-borne
4
nosocomial-borne infection
4

Similar Publications

Background: The river ecosystems provide habitats and source of water for a number of species including humans. The uncontrolled accumulation of pollutants in the aquatic environment enhances the development of antibiotic-resistant bacteria and genes.

Methods: Water samples were collected seasonally from different sites of Gomti and Ganga River.

View Article and Find Full Text PDF

Aims: This study aims to investigate the genomic profile of a multidrug-resistant Escherichia coli strain, 160-11H1, co-carrying an extended-spectrum β-lactamase (ESBL) and the plasmid-mediated mobile colistin resistance gene, mcr-5.

Methods And Results: The entire genome of the strain was sequenced using Illumina MiSeq and Oxford Nanopore platforms, and de novo assembly was performed using Unicycler. The genome size was 5 031,330 bp and comprised 5 140 coding sequences.

View Article and Find Full Text PDF

The complete genomes of three isolates were collected from the same patient in 2014, 2015, and 2016. NIH-016-2 is susceptible to eight antibiotics, while the other two are resistant to 11 commonly used antibiotics. Isolates were sequenced using Nanopore and Illumina short-read technologies.

View Article and Find Full Text PDF

Rapid detection of carbapenemases in multiresistant Gram-negative strains: evaluation of two tests.

Microbiol Spectr

September 2025

Institute for Medical Laboratory Diagnostics, Helios University Hospital, Witten/Herdecke University, Wuppertal, Germany.

Carbapenem-resistant organisms (CRO) have rapidly spread worldwide in recent years, posing a significant challenge to both human health and healthcare systems. Timely and accurate detection of CRO, especially carbapenemase-producing and non-fermenters, is crucial for clinical prevention and treatment of these infections. In the present study, we subjected more than 114 multidrug-resistant Gram-negative and non-fermenters to two tests for the timely detection of carbapenemases.

View Article and Find Full Text PDF

Tuberculosis (TB) remains one of the leading causes of infectious disease mortality worldwide, increasingly complicated by the emergence of drug-resistant strains and limitations in existing diagnostic and therapeutic strategies. Despite decades of global efforts, the disease continues to impose a significant burden, particularly in low- and middle-income countries (LMICs) where health system weaknesses hinder progress. This comprehensive review explores recent advancements in TB diagnostics, antimicrobial resistance (AMR surveillance), treatment strategies, and vaccine development.

View Article and Find Full Text PDF